
JBT Marel Corporation (JBTM) remains a soft ‘buy' despite recent underperformance and a 10.1% stock decline versus the S&P 500. Revenue and profits are rising, with Q2 revenue at $981 million and net income up to $28 million, supporting a positive long-term outlook. Management reaffirmed revenue guidance but lowered adjusted EPS guidance to $7.85–$8.35; EBITDA guidance remains unchanged.










